PARP inhibitors in BRCA mutation-associated ovarian cancer

被引：22
作者：
Clamp, Andrew [1 ]
Jayson, Gordon
机构：
[1] Christie, Inst Canc Sci, Manchester M20 4BX, Lancs, England
来源：
LANCET ONCOLOGY | 2015年 / 16卷 / 01期
关键词：
OLAPARIB MAINTENANCE THERAPY; RANDOMIZED PHASE-2; POLYMERASE;
D O I：
10.1016/S1470-2045(14)71172-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：10 / 12
页数：4
相关论文
共 8 条
  • [1] [Anonymous], LANCET ONCOL
  • [2] Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
    Farmer, H
    McCabe, N
    Lord, CJ
    Tutt, ANJ
    Johnson, DA
    Richardson, TB
    Santarosa, M
    Dillon, KJ
    Hickson, I
    Knights, C
    Martin, NMB
    Jackson, SP
    Smith, GCM
    Ashworth, A
    [J]. NATURE, 2005, 434 (7035) : 917 - 921
  • [3] Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
    Fong, Peter C.
    Boss, David S.
    Yap, Timothy A.
    Tutt, Andrew
    Wu, Peijun
    Mergui-Roelvink, Marja
    Mortimer, Peter
    Swaisland, Helen
    Lau, Alan
    O'Connor, Mark J.
    Ashworth, Alan
    Carmichael, James
    Kaye, Stan B.
    Schellens, Jan H. M.
    de Bono, Johann S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (02) : 123 - 134
  • [4] Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer
    Hennessy, Bryan T. J.
    Timms, Kirsten M.
    Carey, Mark S.
    Gutin, Alexander
    Meyer, Larissa A.
    Flake, Darl D., II
    Abkevich, Victor
    Potter, Jennifer
    Pruss, Dmitry
    Glenn, Pat
    Li, Yang
    Li, Jie
    Gonzalez-Angulo, Ana Maria
    McCune, Karen Smith
    Markman, Maurie
    Broaddus, Russell R.
    Lanchbury, Jerry S.
    Lu, Karen H.
    Mills, Gordon B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (22) : 3570 - 3576
  • [5] Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
    Ledermann, Jonathan
    Harter, Philipp
    Gourley, Charlie
    Friedlander, Michael
    Vergote, Ignace
    Rustin, Gordon
    Scott, Clare L.
    Meier, Werner
    Shapira-Frommer, Ronnie
    Safra, Tamar
    Matei, Daniela
    Fielding, Anitra
    Spencer, Stuart
    Dougherty, Brian
    Orr, Maria
    Hodgson, Darren
    Barrett, J. Carl
    Matulonis, Ursula
    [J]. LANCET ONCOLOGY, 2014, 15 (08) : 852 - 861
  • [6] Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
    Ledermann, Jonathan
    Harter, Philipp
    Gourley, Charlie
    Friedlander, Michael
    Vergote, Ignace
    Rustin, Gordon
    Scott, Clare
    Meier, Werner
    Shapira-Frommer, Ronnie
    Safra, Tamar
    Matei, Daniela
    Macpherson, Euan
    Watkins, Claire
    Carmichael, James
    Matulonis, Ursula
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (15) : 1382 - 1392
  • [7] Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study
    Liu, Joyce F.
    Barry, William T.
    Birrer, Michael
    Lee, Jung-Min
    Buckanovich, Ronald J.
    Fleming, Gini F.
    Rimel, B. J.
    Buss, Mary K.
    Nattam, Sreenivasa
    Hurteau, Jean
    Luo, Weixiu
    Quy, Philippa
    Whalen, Christin
    Obermayer, Lisa
    Lee, Hang
    Winer, Eric P.
    Kohn, Elise C.
    Ivy, S. Percy
    Matulonis, Ursula A.
    [J]. LANCET ONCOLOGY, 2014, 15 (11) : 1207 - 1214
  • [8] BRCAness Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated With BRCA1 and BRCA2 Mutations
    Tan, David S. P.
    Rothermundt, Christian
    Thomas, Karen
    Bancroft, Elizabeth
    Eeles, Rosalind
    Shanley, Susan
    Ardern-Jones, Audrey
    Norman, Andrew
    Kaye, Stanley B.
    Gore, Martin E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (34) : 5530 - 5536
1